DBG
ABMD

De Burlo Group’s Abiomed Inc ABMD Stock Holding History

De Burlo Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,350
Closed -$873K – 92
2019
Q2 		$873K Sell
3,350
-4,100
-55% -$1.09M 0.17% 64
2019
Q1 		$2.13M Sell
7,450
-1,750
-19% -$582K 0.43% 53
2018
Q4 		$2.99M Sell
9,200
-100
-1% -$34.7K 0.67% 43
2018
Q3 		$4.18M Sell
9,300
-33,600
-78% -$13.2M 0.78% 43
2018
Q2 		$17.5M Sell
42,900
-12,050
-22% -$4.37M 3.71% 7
2018
Q1 		$16M Buy
54,950
+5,500
+11% +$1.39M 3.48% 7
2017
Q4 		$9.27M Buy
49,450
+32,550
+193% +$6.08M 1.88% 20
2017
Q3 		$2.85M Buy
+16,900
New +$2.56M 0.63% 46

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

De Burlo Group's ABMD Position: Q3 2019 in Review

De Burlo Group sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 3,350 shares — an estimated $873K sold.

De Burlo Group first reported a position in ABMD in Q3 2017 and held it in 8 quarters. The position peaked at $17.5M in Q2 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • De Burlo Group reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • De Burlo Group sold 3,350 Abiomed Inc shares in Q3 2019, an estimated $873K.
  • De Burlo Group first reported a position in Abiomed Inc in Q3 2017 and held it in 8 quarters.
  • De Burlo Group's Abiomed Inc position peaked at $17.5M in Q2 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on De Burlo Group's 13F filing for Q3 2019, filed 7 Nov 2019.